Pharmaceuticals · 2019 · 27 citations · 33 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryStructure-activity RelationshipsMacrocyclic Drug DesignNatural Product-based Drug DesignAnticancer ActivityAnticancer ChemotherapyAnticancer Compound ScreeningAnticancer Mechanism Of ActionCellular GrowthMedicinal HeterocyclesNatural Product PharmacologyNatural Product Synthesis
Ellipticines have well documented anticancer activity, in particular with substitution at the 1-, 2-, 6- and 9-positions. However, due to limitations in synthesis and coherent screening methodology the full SAR profile of this anticancer class has not yet been achieved. In order to address this shortfall, we have set out to explore the anticancer activity of this potent natural product by substitution. We currently describe the synthesis of novel 11-substituted ellipticines with two specific derivatives showing potency and diverging cellular growth effects.
33
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke, Rileen Sinha, Douglas A. Levine et al. · Nature Communications · 2013 · 1.5K citations · Full text
Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes et al. · JNCI Journal of the National Cancer Institute · 1989 · 969 citations
Medicine, Biostatistics, Oncology +16